Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/11000/31130

Low-Dose Sodium Valproate in the Prophylaxis of Migraine


no-thumbnailVer/Abrir:

 Low-dose sodium valproate in the prophylaxis of migraine.pdf



3,79 MB
Adobe PDF
Compartir:

Este recurso está restringido

Título :
Low-Dose Sodium Valproate in the Prophylaxis of Migraine
Autor :
Coria, Francisco
Perez-Sempere, Angel  
Duarte, Jacinto
Clavería, Luis E.
Cabezas, Carmen  
Bayón, Carmen  
Editor :
Lippincott
Departamento:
Departamentos de la UMH::Medicina Clínica
Fecha de publicación:
1994-12
URI :
https://hdl.handle.net/11000/31130
Resumen :
The potential therapeutic effect of sodium valproate (VPA) on the prophylaxis of migraine was assessed in 62 consecutive patients with severe migraine with and without aura subjected to an open label trial. Patients were given 400 mg VPA daily, divided in two oral doses, during 3 months and then asked to withdraw the drug for 3 months. The therapeutic response was measured with a scale of 15 items that assess the frequency and severity of migraine attacks, and the possible toxic side-effects were monitored by determinations of blood cells, liver enzymes, serum ammonia levels, and plasma VPA levels. Results indicate that 69.8% of patients obtained substantial benefit from this drug and that this beneficial effect lasted for at least 3 months after drug withdrawal in 67.6% of cases. No significant correlation was found between VPA levels and the therapeutic response as measured by the Migraine Assessment Scale. No serious side-effects were observed during the trial. Low-dose VPA is a safe alternative in the prophylaxis of severe migraine.
Palabras clave/Materias:
Migraine
Headache
Sodium valproate
Área de conocimiento :
CDU: Ciencias aplicadas: Medicina: Patología. Medicina clínica. Oncología
Tipo documento :
application/pdf
Derechos de acceso:
info:eu-repo/semantics/closedAccess
Aparece en las colecciones:
Artículos Medicina Clínica



Creative Commons La licencia se describe como: Atribución-NonComercial-NoDerivada 4.0 Internacional.